JP Morgan Chase’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

JP Morgan Chase’s Portfolio MIRO Stock Details MIRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-23	Closed	-$28	–	8020
2023 Q3	$28	Buy	+23	New	+$34	﹤0.01%	7106
2023 Q1	–	Sell	-1,645	Closed	-$5K	–	7390
2022 Q4	$5K	Buy	+1,645	New	+$6.45K	﹤0.01%	6180

JP Morgan Chase's MIRO Position: Q4 2023 in Review

JP Morgan Chase sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 23 shares — an estimated $28 sold.

JP Morgan Chase first reported a position in MIRO in Q4 2022 and held it in 2 quarters. The position peaked at $5K in Q4 2022. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

JP Morgan Chase reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
JP Morgan Chase sold 23 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $28.
JP Morgan Chase first reported a position in Miromatrix Medical Inc. Common Stock in Q4 2022 and held it in 2 quarters.
JP Morgan Chase's Miromatrix Medical Inc. Common Stock position peaked at $5K in Q4 2022.
0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.